60,000 isn't too bad. If PSRU doesn't perform you won't be out too much (though I realize everything's relative) and if they survive and thrive you can make a nice profit.
This silence is for the birds. They need to come out and tell shareholders something. If they can't discuss the merger yet, then they need to share something else with shareholders, something regarding sales or the NYC trials, SOMETHING. Because we don't know for sure if a merger is in the works or if this product sharing deal is all that will come of the PSRU/UT relationship. I still tend to think something will come of the negotiations with UT. The question continues to be, what will it mean to the shareholders. If this potential deal with UT is the only thing PSRU has going for it and UT's business is relatively strong, then it probably doesn't bode well for shareholders. But the opposite is true as well. If PSRU's sales are strong and there's no problem with their dimmable ballast but UT is on their last leg, then PureSpectrum and their shareholders have the advantage. Good luck.
Market Data 
Markets 
AI
